Published in EMBO J on November 15, 2000
Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J (2003) 10.77
Identification of nucleocytoplasmic cycling as a remote sensor in cellular signaling by databased modeling. Proc Natl Acad Sci U S A (2003) 3.91
Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol (2002) 3.57
Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol (2006) 3.50
Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol (2002) 2.68
Genome-wide RNAi analysis of JAK/STAT signaling components in Drosophila. Genes Dev (2005) 2.63
Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J Exp Med (2004) 2.55
Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol Cell Biol (2001) 2.32
STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. Proc Natl Acad Sci U S A (2005) 2.32
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol (2007) 2.18
Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J Virol (2002) 2.08
Constitutive and IFN-gamma-induced nuclear import of STAT1 proceed through independent pathways. EMBO J (2002) 2.01
Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha. EMBO J (2002) 2.01
Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol Cell Biol (2001) 1.68
DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1. Genes Dev (2003) 1.68
Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. Proc Natl Acad Sci U S A (2005) 1.68
Series introduction. JAK-STAT signaling in human disease. J Clin Invest (2002) 1.54
Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1. J Cell Biol (2004) 1.54
Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol (2012) 1.51
Regulation of Stat3 nuclear export. J Clin Invest (2003) 1.46
Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain. Proc Natl Acad Sci U S A (2008) 1.43
STAT1 from the cell membrane to the DNA. EMBO J (2001) 1.36
Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation. Mol Cell Biol (2002) 1.30
Biology and significance of the JAK/STAT signalling pathways. Growth Factors (2012) 1.29
Getting the message across, STAT! Design principles of a molecular signaling circuit. J Cell Biol (2004) 1.25
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer. Oncogene (2009) 1.24
Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. Mol Cell Biol (2008) 1.19
Multiple transcription factor families regulate axon growth and regeneration. Dev Neurobiol (2011) 1.13
The DNA damage response induces IFN. J Immunol (2011) 1.13
Stat1 and SUMO modification. Blood (2006) 1.12
The interferon signaling network and transcription factor C/EBP-beta. Cell Mol Immunol (2007) 1.12
Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification. Proc Natl Acad Sci U S A (2001) 1.11
The adenovirus type 5 E1B-55K oncoprotein actively shuttles in virus-infected cells, whereas transport of E4orf6 is mediated by a CRM1-independent mechanism. J Virol (2001) 1.11
STATs get their move on. JAKSTAT (2013) 1.08
STAT dynamics. Cytokine Growth Factor Rev (2007) 1.00
Live cell imaging reveals continuous STAT6 nuclear trafficking. J Immunol (2010) 1.00
The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. Biochem J (2004) 0.98
Controlling nuclear JAKs and STATs for specific gene activation by IFNγ. Biochem Biophys Res Commun (2011) 0.95
New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain. J Biol Chem (2009) 0.94
Nucleocytoplasmic shuttling of the adapter protein SH2B1beta (SH2-Bbeta) is required for nerve growth factor (NGF)-dependent neurite outgrowth and enhancement of expression of a subset of NGF-responsive genes. Mol Endocrinol (2009) 0.93
Adapter protein SH2-B beta undergoes nucleocytoplasmic shuttling: implications for nerve growth factor induction of neuronal differentiation. Mol Cell Biol (2004) 0.92
Two domains of the V protein of virulent canine distemper virus selectively inhibit STAT1 and STAT2 nuclear import. J Virol (2010) 0.91
Leptin signaling and Alzheimer's disease. Am J Neurodegener Dis (2012) 0.88
The role of STAT3 in autophagy. Autophagy (2015) 0.88
A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3. EMBO J (2002) 0.87
Steroid-like signalling by interferons: making sense of specific gene activation by cytokines. Biochem J (2012) 0.87
Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation. J Virol (2011) 0.83
Nucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expression. J Biol Chem (2010) 0.82
Interferon gamma is recognised by importin alpha/beta: enhanced nuclear localising and transactivation activities of an interferon gamma mimetic. FEBS Lett (2008) 0.82
Response to interferons and antibacterial innate immunity in the absence of tyrosine-phosphorylated STAT1. EMBO Rep (2016) 0.81
Deregulation of Interferon Signaling in Malignant Cells. Pharmaceuticals (Basel) (2010) 0.81
Regulation of the Drosophila hypoxia-inducible factor alpha Sima by CRM1-dependent nuclear export. Mol Cell Biol (2008) 0.81
Structural and functional studies of STAT1 from Atlantic salmon (Salmo salar). BMC Immunol (2010) 0.81
Mutations that reduce its specific DNA binding inhibit high NaCl-induced nuclear localization of the osmoprotective transcription factor NFAT5. Am J Physiol Cell Physiol (2012) 0.79
A critical role for CRM1 in regulating HOXA gene transcription in CALM-AF10 leukemias. Leukemia (2014) 0.79
Elucidating the crosstalk mechanism between IFN-gamma and IL-6 via mathematical modelling. BMC Bioinformatics (2013) 0.78
Structural and functional characterization of salmon STAT1, STAT2 and IRF9 homologs sheds light on interferon signaling in teleosts. FEBS Open Bio (2014) 0.77
Cytokine-induced nuclear translocation of signaling proteins and their analysis using the inducible translocation trap system. Cytokine (2008) 0.77
Controlling Nuclear Jaks and Stats for Specific Gene Activation by Ifn γ and Other Cytokines: A Possible Steroid-like Connection. J Clin Cell Immunol (2011) 0.77
Importins promote high-frequency NF-κB oscillations increasing information channel capacity. Biol Direct (2016) 0.75
Esterase 1 is a novel transcriptional repressor of growth hormone receptor gene expression: a unique noncatalytic role for a carboxyesterase protein. Mol Endocrinol (2011) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Green fluorescent protein as a marker for gene expression. Science (1994) 34.55
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol (1998) 21.48
Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell (1979) 21.15
CRM1 is an export receptor for leucine-rich nuclear export signals. Cell (1997) 18.60
Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr (1994) 17.44
Stat3 as an oncogene. Cell (1999) 17.39
Nuclear targeting sequences--a consensus? Trends Biochem Sci (1991) 16.65
STATs and gene regulation. Science (1997) 16.55
Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem (1991) 16.18
Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol (1999) 13.27
Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem (1998) 10.74
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell (1996) 10.49
Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell (1996) 10.44
Exportin 1 (Crm1p) is an essential nuclear export factor. Cell (1997) 10.32
The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell (1995) 9.98
Identification of a signal for rapid export of proteins from the nucleus. Cell (1995) 9.92
Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem (1995) 8.52
Understanding, improving and using green fluorescent proteins. Trends Biochem Sci (1995) 7.51
Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature (1997) 7.47
Jaks and STATs: biological implications. Annu Rev Immunol (1998) 7.18
PROMOTIF--a program to identify and analyze structural motifs in proteins. Protein Sci (1996) 6.76
A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science (1993) 6.44
Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res (1998) 6.11
Transport of proteins and RNAs in and out of the nucleus. Cell (1999) 6.02
Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell (1994) 5.79
Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol (1997) 5.49
The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol (1997) 4.76
A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J (1999) 4.68
Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J (1993) 4.35
Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell (1999) 4.19
Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci U S A (1998) 4.12
A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev (1995) 4.11
Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay. Mol Cell Biol (1996) 4.10
Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol Cell (1999) 4.02
Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell (1998) 3.79
Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem (1997) 3.20
The nuclear pore complex. Annu Rev Biochem (1995) 3.20
Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J Biol Chem (1996) 3.11
Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes Dev (1998) 2.84
Nuclear export receptors: from importin to exportin. Cell (1997) 2.82
Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1. EMBO J (1997) 2.80
Requirement of guanosine triphosphate-bound ran for signal-mediated nuclear protein export. Science (1997) 2.74
Regulation of nuclear localization: a key to a door. Annu Rev Cell Dev Biol (1999) 2.74
Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol (1995) 2.61
Importins and exportins: how to get in and out of the nucleus. Trends Biochem Sci (1998) 2.58
Transport routes through the nuclear pore complex. Curr Opin Cell Biol (1998) 2.50
Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol Cell Biol (2000) 2.24
A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1. Proc Natl Acad Sci U S A (1999) 2.07
Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science (1993) 2.00
Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol (1995) 1.83
Using GFP to see the light. Trends Genet (1995) 1.80
Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity (1995) 1.77
Negative regulators of cytokine signal transduction. Cell Mol Life Sci (1999) 1.71
Characterization of the nuclear export signal of human T-cell lymphotropic virus type 1 Rex reveals that nuclear export is mediated by position-variable hydrophobic interactions. Mol Cell Biol (1996) 1.69
Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. J Biol Chem (2000) 1.63
Regulation of interferon-alpha responsiveness by the duration of Janus kinase activity. J Biol Chem (1997) 1.48
In vitro activation of a transcription factor by gamma interferon requires a membrane-associated tyrosine kinase and is mimicked by vanadate. Mol Cell Biol (1993) 1.44
Dynamic redistribution of STAT1 protein in IFN signaling visualized by GFP fusion proteins. Eur J Biochem (1999) 1.30
Amino-terminal signal transducer and activator of transcription (STAT) domains regulate nuclear translocation and STAT deactivation. J Biol Chem (1998) 1.22
Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3. J Biol Chem (1997) 1.20
A functional DNA binding domain is required for growth hormone-induced nuclear accumulation of Stat5B. J Biol Chem (1999) 1.19
Cytoplasmic retention of Xenopus nuclear factor 7 before the mid blastula transition uses a unique anchoring mechanism involving a retention domain and several phosphorylation sites. J Cell Biol (1994) 1.17
The Janus kinase family of protein tyrosine kinases and their role in signaling. Cell Mol Life Sci (1999) 1.15
Design of conditionally active STATs: insights into STAT activation and gene regulatory function. Mol Cell Biol (1999) 1.11
Role of the STAT1-SH2 domain and STAT2 in the activation and nuclear translocation of STAT1. J Biol Chem (1998) 1.08
Regulation of steroid receptor subcellular trafficking. Cell Biochem Biophys (1999) 0.95
In vitro systems for the reconstitution of snRNP and protein nuclear import. Methods Cell Biol (1998) 0.87
Structural and mechanistic aspects of Janus kinases: how the two-faced god wields a double-edged sword. J Interferon Cytokine Res (1998) 0.81
Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature (1984) 4.86
Residential care for elderly people: a decade of change. BMJ (1993) 3.71
Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol (1998) 3.70
Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph? Lancet (1995) 3.59
Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol Cell Biol (1983) 3.39
Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current. Circ Res (1996) 3.23
Risk of breast cancer in women with palpable breast cysts: a prospective study. Edinburgh Breast Group. Lancet (1999) 2.91
Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology (1983) 2.69
Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol Cell Biol (2000) 2.24
The amino acid sequence of murine p53 determined from a c-DNA clone. Virology (1984) 2.15
Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element. Mol Cell Biol (1993) 2.03
Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science (1993) 2.00
IRF-3-dependent and augmented target genes during viral infection. Genes Immun (2007) 1.94
Dependency and self-criticism: psychological dimensions of depression. J Consult Clin Psychol (1982) 1.89
Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny. Mol Cell Biol (1982) 1.82
Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci U S A (2005) 1.79
A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy. Bone Marrow Transplant (2006) 1.66
The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer (1994) 1.65
Diet and drinking habits in relation to the development of alcoholic pancreatitis. Gut (1985) 1.55
Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc Natl Acad Sci U S A (1991) 1.54
The structure of anxiety symptoms among preschoolers. Behav Res Ther (2001) 1.52
Cyclosporine as maintenance therapy in patients with severe psoriasis. J Am Acad Dermatol (1997) 1.51
Characterization of specific DNA-binding factors activated by double-stranded RNA as positive regulators of interferon alpha/beta-stimulated genes. J Biol Chem (1995) 1.48
Rac1 mediates STAT3 activation by autocrine IL-6. Proc Natl Acad Sci U S A (2001) 1.46
Obstetric complications in patients with schizophrenia and their unaffected siblings. Eur Psychiatry (2005) 1.45
Fluctuations in syringe-pump infusions: association with blood pressure variations in infants. Am J Health Syst Pharm (1995) 1.44
Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol (1993) 1.44
The epithelial cell response to rotavirus infection. J Immunol (1999) 1.44
Data base management, feedback control, and the Regenstrief Medical Record. J Med Syst (1983) 1.40
Identification of STAT3 as a specific substrate of breast tumor kinase. Oncogene (2006) 1.40
Ultrasonographic evaluation of diaphragmatic motion. J Ultrasound Med (2001) 1.39
A comparison of geriatric day hospitals in Fife. Health Bull (Edinb) (1990) 1.39
Hepatitis B surface antigen: preliminary evaluation of a latex agglutination test. Med Lab Sci (1988) 1.39
Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang (2004) 1.38
Apoptosis is promoted by the dsRNA-activated factor (DRAF1) during viral infection independent of the action of interferon or p53. FASEB J (2001) 1.37
Measurement of grip strength: validity and reliability of the sphygmomanometer and jamar grip dynamometer. J Orthop Sports Phys Ther (1992) 1.33
Exaggerated neural response to emotional faces in patients with bipolar disorder and their first-degree relatives. Neuroimage (2010) 1.25
Tyrosine phosphorylation is required for activation of an alpha interferon-stimulated transcription factor. Proc Natl Acad Sci U S A (1992) 1.22
Clinical heterogeneity in senile dementia. Br J Psychiatry (1969) 1.22
Specific interaction of the SV40 T antigen-cellular p53 protein complex with SV40 DNA. Virology (1982) 1.22
Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3. J Biol Chem (1997) 1.20
Measuring the human retinal oxygenation response to a hyperoxic challenge using MRI: eliminating blinking artifacts and demonstrating proof of concept. Magn Reson Med (2001) 1.19
Transmembrane signaling by interferon alpha involves diacylglycerol production and activation of the epsilon isoform of protein kinase C in Daudi cells. Proc Natl Acad Sci U S A (1991) 1.19
The ultrasound appearance of the normal psoas muscle. Clin Radiol (1993) 1.16
Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial. Ann Intern Med (1990) 1.15
Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease. J Geriatr Psychiatry Neurol (1999) 1.14
Brain MRI abnormalities in schizophrenia: same genes or same environment? Psychol Med (2005) 1.14
Spinal sonography and magnetic resonance imaging in patients with repaired myelomeningocele: comparison of modalities. J Ultrasound Med (1999) 1.14
RCPE UK consensus conference on 'Acute medicine: improving quality of care through effective patient flow--it's everyone's business!'. J R Coll Physicians Edinb (2013) 1.12
Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors. Proc Natl Acad Sci U S A (1994) 1.09
Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells. Antimicrob Agents Chemother (1994) 1.08
Isolation and characterisation of genes for androgen-responsive secretory proteins of rat seminal vesicles. Nucleic Acids Res (1983) 1.07
Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study. Psychol Med (2009) 1.05
Cooperation of the transcriptional coactivators CBP and p300 with Stat6. J Interferon Cytokine Res (1999) 1.04
Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene. J Biol Chem (1996) 1.04
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry (2015) 1.03
Diagnosis of genital herpes by real time PCR in routine clinical practice. Sex Transm Infect (2004) 1.03
The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Psychol Med (2009) 1.01
Signal transduction and activation of gene transcription by interferons. Gene Expr (1995) 1.00
Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci (2001) 1.00
Winter mortality in relation to climate. Int J Circumpolar Health (2000) 0.99
Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome. Br J Ophthalmol (1999) 0.99
Involvement of protein phosphatase 2A in the interleukin-3-stimulated Jak2-Stat5 signaling pathway. J Interferon Cytokine Res (2001) 0.98
Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137. Neurosci Lett (2012) 0.98
Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci U S A (1995) 0.98
Effect of disrupted-in-schizophrenia-1 on pre-frontal cortical function. Mol Psychiatry (2008) 0.97
Gastric emptying of solid food in patients with gastroesophageal reflux. Gastroenterology (1987) 0.97
Characterization of the interleukin-4 nuclear activated factor/STAT and its activation independent of the insulin receptor substrate proteins. J Biol Chem (1995) 0.96
Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow'). Aliment Pharmacol Ther (2012) 0.95
Serologic evaluation of cattle inoculated with Toxoplasma gondii: comparison of Sabin-Feldman dye test and other agglutination tests. Am J Vet Res (1985) 0.95
Cloning and characterization of soluble and transmembrane isoforms of a novel component of the murine type I interferon receptor, IFNAR 2. J Biol Chem (1997) 0.95
Orthostatic symptoms predict functional capacity in chronic fatigue syndrome: implications for management. QJM (2010) 0.95
Evaluation of barley chromosome-3 yield QTLs in a backcross F2 population using STS-PCR. Theor Appl Genet (1996) 0.94
Small intestinal function and dietary status in dermatitis herpetiformis. Gut (1991) 0.92
A controlled study of crude-spirits drinkers. Med J Aust (1967) 0.91
Case report: gastrointestinal tuberculosis simulating Crohn's disease. J Gastroenterol Hepatol (1996) 0.91
Clinical symptomatology and the psychosis risk gene ZNF804A. Schizophr Res (2010) 0.91
Dominant endosteal hyperostosis. Skeletal characteristics and review of the literature. J Bone Joint Surg Am (2001) 0.91
Inhalation accidents reported to the SWORD surveillance project 1990-1993. Ann Occup Hyg (1996) 0.89
Lexical priming on Neely's (1977) paradigm in Parkinson's disease: where do we stand? J Clin Exp Neuropsychol (1999) 0.89
Paediatric and perinatal HIV/AIDS in Jamaica an international leadership initiative, 2002-2007. West Indian Med J (2008) 0.89
Detection of bacterial contamination of platelet concentrates. Vox Sang (2007) 0.88
T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement. Br J Haematol (2001) 0.88
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration. Bone Marrow Transplant (2011) 0.87
Serologic diagnosis of toxoplasmosis in experimentally infected pregnant goats and transplacentally infected kids. Am J Vet Res (1985) 0.86
Survey of Salmonella contamination of raw shell eggs used in food service premises in the United Kingdom, 2005 through 2006. J Food Prot (2008) 0.86
The effect on syringe performance of fluid storage and repeated use: implications for syringe pumps. PDA J Pharm Sci Technol (1996) 0.86
Treatment of the mentally disturbed geriatric patient. Geriatrics (1968) 0.86
Neurobiological trait abnormalities in bipolar disorder. Mol Psychiatry (2009) 0.86
Sequence organisation of rat seminal vesicle F gene: location of transcriptional start point and sequence comparison with six other androgen-regulated genes. Nucleic Acids Res (1985) 0.85
Interferon signal transduction. Biotherapy (1996) 0.85
A study of hippocampal shape anomaly in schizophrenia and in families multiply affected by schizophrenia or bipolar disorder. Neuroradiology (2004) 0.85
Fulminant demyelinating neuropathy mimicking cerebral death. Muscle Nerve (1997) 0.85
Motor scores on the functional independence measure after pediatric spinal cord injury. Spinal Cord (2008) 0.84
Genetic modelling of childhood social development and personality in twins and siblings with schizophrenia. Psychol Med (2009) 0.84
Re-evaluating the role of His-143 in the mechanism of type I dehydroquinase from Escherichia coli using two-dimensional 1H,13C NMR. J Biol Chem (1998) 0.84
Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines. Leukemia (1994) 0.84
Comparison of two techniques for targeting the production of monoclonal antibodies against particular antigens. J Immunol Methods (1991) 0.84